FindTrial
Sign In

Use of MEOPA by elderly with dementia

Use of MEOPA by elderly with dementia

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2008-000239-17-FR
Enrollment
Unknown
Registered
2008-04-10
Start date
2008-05-06
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PAIN DUE TO BEDSORE OR WOUND BY ELDERLY WITH DEMENTIA MedDRA version: 9.1 Level: LLT Classification code 10056350 Term: Pain management

Interventions

Trade Name: KALINOX Product Name: MEOPA Pharmaceutical Form: Inhalation gas

Sponsors

CHU de NICE
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: PATIENTS OLDER THAN 75 DIAGNOSTIC OF DEMENTIA NECESSITY OF PAIN MANAGEMENT Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: CHANGE OF MEDICATION OR ANALGESIC < 24 HOURS

Design outcomes

Primary

MeasureTime frame
Main Objective: ASSESSMENT OF USE OF MEOPA BY ELDERLY WITH DEMENTIA AS A SUBSTITUTION OF USE OF OPIODS DURING PAINFULL CARE ;Secondary Objective: DESCRIPTION OF SECONDARY EFFECTS SATISFACTION ASSESSMENT OF PATIENTS AND NURSE STUDY OF ASSOCIATION BETWEEN TOLERANCE TO MEOPA AND DEGREE OF DEMENTIA;Primary end point(s): PAIN ASSESSMENT SATISFACTION OF PATIENTS AND NURSE—

Countries

France

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026